HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute Basophilic Leukemia

A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.
Also Known As:
Leukemia, Basophilic, Acute; Acute Basophilic Leukemias; Basophilic Leukemias, Acute; Leukemia, Acute Basophilic; Leukemias, Acute Basophilic; Basophilic Leukemia, Acute
Networked: 13 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1. BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
2. Leukemia
3. Disease Progression
4. Acute Eosinophilic Leukemia
5. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

Experts

1. Cao, Lei: 1 article (02/2020)
2. He, Guang-Sheng: 1 article (02/2020)
3. Li, Jian-Yong: 1 article (02/2020)
4. Long, Qi-Qiang: 1 article (02/2020)
5. Wang, Rong: 1 article (02/2020)
6. Wang, Yan: 1 article (02/2020)
7. Xu, Ji: 1 article (02/2020)
8. Yang, Hui: 1 article (02/2020)
9. Zhao, Si-Shu: 1 article (02/2020)
10. Fry, Elizabeth A: 1 article (01/2019)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Acute Basophilic Leukemia:
1. Histamine (Histamine Dihydrochloride)FDA Link
2. Pyridinolcarbamate (P23)IBA
3. Imatinib Mesylate (Gleevec)FDA Link
4. Cytokine Receptors (Cytokine Receptor)IBA
5. Interferon-alpha (Interferon Alfa)IBA
6. Messenger RNA (mRNA)IBA
7. Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
8. Hydroxyurea (Hydrea)FDA LinkGeneric
9. AntigensIBA
10. Arsenic Trioxide (Trisenox)FDA Link

Therapies and Procedures

1. Therapeutics